diff --git a/content/3.defense-systems/kiwa.md b/content/3.defense-systems/kiwa.md
index c27a42ee2588c9ef4a8e0ce04208938828a9d8fa..ea4fad102ea5d97bc5d1357fd0f3938dd5c3d7df 100644
--- a/content/3.defense-systems/kiwa.md
+++ b/content/3.defense-systems/kiwa.md
@@ -10,9 +10,23 @@ tableColumns:
     Activator: Unknown
     Effector: Unknown
     PFAM: PF16162
+contributors: 
+  - Lucas Paoli
+relevantAbstracts:
+  - doi: 10.1126/science.aar4120
+  - doi: 10.1101/2023.02.26.530102
 ---
 
 # Kiwa
+
+## Description
+
+The Kiwa antiviral defense system was first described by Doron et al. 2018 :ref{doi=10.1126/science.aar4120} and further described by Todeschini et al. 2023 :ref{doi=10.1101/2023.02.26.530102}. It named after one of the divine guardians of the ocean in the Māori traditions.
+
+## Molecular mechanisms
+
+Kiwa is composed of two proteins: KwaA and KwaB. KwaA detects phage infection by detecting the inhibition of the host RNA polymerase by phages. This triggers the reponse by KwaB, which decreases phage DNA replication through a RecBCD-depdendent pathway :ref{doi=10.1101/2023.02.26.530102}..
+
 ## Example of genomic structure
 
 The Kiwa system is composed of 2 proteins: KwaA and, KwaB.
@@ -76,13 +90,4 @@ end
     style Title3 fill:none,stroke:none,stroke-width:none
     style Title4 fill:none,stroke:none,stroke-width:none
 </mermaid>
-## Relevant abstracts
-
-::relevant-abstracts
----
-items:
-    - doi: 10.1126/science.aar4120
-
----
-::